Danaher | DHR - Net Income

Stock Price
180.62
Daily Change
3.37 1.90%
Monthly
-1.78%
Yearly
-7.80%
Q2 Forecast
173.46

Danaher reported $1.03B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Agilent USD 305M 129M Dec/2025
Align Technology USD 135.76M 79.01M Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Bio Techne USD 38.01M 176K Dec/2025
Bio-Rad Laboratories USD -341.9M 659.7M Sep/2025
Boston Scientific USD 1.34B 669M Mar/2026
Bruker USD 26M 88.4M Dec/2025
Charles River Laboratories USD -276.56M 330.98M Dec/2025
Danaher USD 1.03B 168M Mar/2026
Dentsply International USD -146M 281M Dec/2025
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
ESCO Technologies USD 28.69M 189.96M Dec/2025
Fortive USD 185.7M 130.7M Dec/2025
Henry Schein USD 101M 0 Dec/2025
Illumina USD 334M 184M Dec/2025
Intuitive Surgical USD 821.5M 26.7M Mar/2026
IQVIA Holdings USD 514M 183M Dec/2025
Keysight Technologies USD 281M 52M Dec/2025
Laboratory Of America USD 164.7M 96.4M Dec/2025
Medtronic USD 1.14B 231M Dec/2025
Mettler Toledo International USD 285.76M 68.27M Dec/2025
Myriad Genetics USD -7.9M 19.5M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Quest Diagnostics USD 251M 6M Mar/2026
Quidel USD -733M 477.6M Sep/2025
Repligen USD 13.29M 1.62M Dec/2025
Revvity USD 98.36M 51.71M Dec/2025
Roper Industries USD 508.9M 80.5M Mar/2026
Stryker USD 849M 10M Dec/2025
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Waters USD 225.21M 76.29M Dec/2025
Zimmer Biomet Holdings USD 139.3M 91.6M Dec/2025